[6] [10] According to NICE guidance, semaglutide 2.4 mg (Wegovy) is recommended for adults with a BMI 35 kg/m and at least one weight-related comorbidity, while liraglutide 3 mg (Saxenda) is recommended for adults with a BMI 35 kg/m who have non-diabetic hyperglycaemia and high cardiovascular risk
Hydration, symptom mitigation, and renal monitoring are prudent in higher-risk patients
Potassium and magnesium are also essential because they support healthy muscles, nerve communication and normal energy production
To longtime GLP-1 researchers like Holst, its weight loss effects werent actually, in aggregate, that dramatic
Initially developed for treating type 2 diabetes, their remarkable impact on weight loss soon became apparent
They still need community, accountability, and education to sustain progress and results